Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
Journal:
Journal of Alzheimer's disease : JAD
Published Date:
Jan 1, 2021
Abstract
BACKGROUND: Many neurocognitive and neuropsychological tests are used to classify early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI), and Alzheimer's disease (AD) from cognitive normal (CN). This can make it challenging for clinicians to make efficient and objective clinical diagnoses. It is possible to reduce the number of variables needed to make a reasonably accurate classification using machine learning.